<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-80372</identifier>
<setSpec>0210-5705</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Study of celiac disease in adults with type 1 diabetes mellitus</dc:title>
<dc:description xml:lang="en">Celiac disease (CD) presents a wide clinical spectrum. There are asymptomatic or oligosymptomatic forms, which are difficult to diagnose. Since patients with untreated CD can develop severe complications, early diagnosis of these forms is important. Consequently, in groups at risk for CD, such as patients with type 1 diabetes (DM1), screening through determination of antigliadin (AGA), anti-tissue transglutaminase (ATG) and antiendomysial antibodies (EMA) is recommended. In the present study, 463 DM1 patients were screened for these antibodies. Patients who were positive for one or more were offered an upper endoscopy to obtain distal duodenum biopsies. Histological lesions, when present, were classified using Marsh's classification. Of the 463 patients, 62 (13.4%) were positive for at least one of the three antibodies, and 42 accepted to undergo an endoscopy. Fourteen patients (3% of the DM1 patients) were histologically diagnosed with CD. Most of these patients had no symptoms of CD, although some showed laboratory findings frequent in CD. The presence of clinical or analytical data compatible with CD was independent of the grade of histological lesions. Finally, we calculated the sensitivity and positive predictive value for each antibody. The most sensitive were ATG and EMA. Because of the technical simplicity of determining ATG with ELISA, in our opinion, this test should be the option of choice for screening (AU)</dc:description>
<dc:creator>Vicuña Arregui, Miren</dc:creator>
<dc:creator>Zozaya Urmeneta, José Manuel</dc:creator>
<dc:creator>Pineda Arribas, Javier</dc:creator>
<dc:creator>Layana Echezuri, Eduardo</dc:creator>
<dc:creator>Menéndez Torre, Edelmiro</dc:creator>
<dc:creator>Jiménez Pérez, Francisco Javier</dc:creator>
<dc:creator>Martínez de Esteban, Juan Pablo</dc:creator>
<dc:creator>Martínez-Peñuela Virseda, María</dc:creator>
<dc:creator>Rodríguez Gutiérrez, Cristina</dc:creator>
<dc:creator>Forga Llenas, Lluis</dc:creator>
<dc:creator>Carral Martínez, David</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">En el presente estudio determinamos los citados anticuerpos a 463 pacientes con DM1 y, a los que presentaban positividad para alguno de ellos, se les propuso la realización de una endoscopia con toma de biopsias de duodeno distal, y se clasificaron las lesiones histológicas, cuando existieron, según la clasificación de Marsh.Sesenta y dos de los 463 (13,4%) pacientes presentaron al menos uno de los 3 anticuerpos positivo y, de ellos, 42 accedieron a la realización de la endoscopia. En 14 pacientes (3% de los diabéticos) se encontraron alteraciones histológicas compatibles con EC. La mayoría de estos 14 pacientes no refería síntomas relacionados con la enfermedad, aunque varios presentaban alteraciones analíticas presentes frecuentemente en la EC. La existencia de datos clinicoanalíticos compatibles con EC fue independiente del grado de lesión histológica. Al analizar la sensibilidad y el valor predictivo positivo para cada anticuerpo, los ATG y EMA fueron los más sensibles, si bien la facilidad técnica de detección de los ATG mediante técnicas de ELISA hace, en nuestra opinión, que sea el de elección para la realización del cribado(AU)</dc:description>
<dc:source>Gastroenterol Hepatol;33(1): 6-11, ener. 2010. graf, tab</dc:source>
<dc:identifier>ibc-80372</dc:identifier>
<dc:title xml:lang="es">Estudio de enfermedad celíaca en pacientes adultos con diabetes mellitus de tipo 1</dc:title>
<dc:subject>^d29315</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d28584</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d2481^s22080</dc:subject>
<dc:subject>^d2481^s22016</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d2481^s22012</dc:subject>
<dc:subject>^d19059</dc:subject>
<dc:subject>^d3944^s22012</dc:subject>
<dc:type>article</dc:type>
<dc:date>201001</dc:date>
</metadata>
</record>
</ibecs-document>
